SI2437782T1 - Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino - Google Patents

Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino

Info

Publication number
SI2437782T1
SI2437782T1 SI201030408T SI201030408T SI2437782T1 SI 2437782 T1 SI2437782 T1 SI 2437782T1 SI 201030408 T SI201030408 T SI 201030408T SI 201030408 T SI201030408 T SI 201030408T SI 2437782 T1 SI2437782 T1 SI 2437782T1
Authority
SI
Slovenia
Prior art keywords
adrenergic compound
stabilised composition
stabilised
composition
adrenergic
Prior art date
Application number
SI201030408T
Other languages
English (en)
Slovenian (sl)
Inventor
Alan J. Baillie
Kenneth Macdonald
Pamela Porteous
Simon Hendry
Original Assignee
Alk Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Ag filed Critical Alk Ag
Publication of SI2437782T1 publication Critical patent/SI2437782T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201030408T 2009-06-04 2010-06-03 Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino SI2437782T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18406609P 2009-06-04 2009-06-04
DKPA200900705 2009-06-04
PCT/EP2010/057771 WO2010139751A2 (en) 2009-06-04 2010-06-03 Stabilised composition comprising at least one adrenergic compound
EP10734927.6A EP2437782B1 (en) 2009-06-04 2010-06-03 Stabilised composition comprising at least one adrenergic compound

Publications (1)

Publication Number Publication Date
SI2437782T1 true SI2437782T1 (sl) 2013-12-31

Family

ID=41364279

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201030408T SI2437782T1 (sl) 2009-06-04 2010-06-03 Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino
SI201030409T SI2437781T1 (sl) 2009-06-04 2010-06-03 Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201030409T SI2437781T1 (sl) 2009-06-04 2010-06-03 Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino

Country Status (15)

Country Link
US (1) US9155694B2 (cg-RX-API-DMAC7.html)
EP (2) EP2437782B1 (cg-RX-API-DMAC7.html)
JP (2) JP2012528830A (cg-RX-API-DMAC7.html)
KR (2) KR20120044309A (cg-RX-API-DMAC7.html)
CN (3) CN102802668A (cg-RX-API-DMAC7.html)
AU (2) AU2010255747B2 (cg-RX-API-DMAC7.html)
BR (2) BRPI1013019A2 (cg-RX-API-DMAC7.html)
CA (2) CA2764050C (cg-RX-API-DMAC7.html)
DK (2) DK2437781T3 (cg-RX-API-DMAC7.html)
ES (2) ES2432241T3 (cg-RX-API-DMAC7.html)
MX (2) MX2011012735A (cg-RX-API-DMAC7.html)
PT (2) PT2437782E (cg-RX-API-DMAC7.html)
RU (2) RU2527680C2 (cg-RX-API-DMAC7.html)
SI (2) SI2437782T1 (cg-RX-API-DMAC7.html)
WO (2) WO2010139752A2 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
CN102525893B (zh) * 2012-01-04 2013-11-20 上海禾丰制药有限公司 盐酸去氧肾上腺素注射液及其制剂工艺
CN102525894A (zh) * 2012-01-04 2012-07-04 上海禾丰制药有限公司 盐酸异丙肾上腺素注射液及其制剂工艺
AU2013328393A1 (en) * 2012-10-08 2015-04-09 Wockhardt Limited Stable injectable pharmaceutical composition of epinephrine or salts thereof
TWI780236B (zh) * 2013-02-04 2022-10-11 法商賽諾菲公司 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
US20150231334A1 (en) * 2013-12-18 2015-08-20 Windgap Medical, Inc. Drug mixing and delivery system and method
US12239822B2 (en) 2013-03-15 2025-03-04 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
KR20160070077A (ko) 2013-10-03 2016-06-17 임프리미스 파마슈티컬스 인코포레이티드 안구내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조 방법
CN103520096B (zh) * 2013-10-25 2015-02-25 成都晶博生物科技有限责任公司 一种硫酸特布他林注射液的生产工艺
KR20160104724A (ko) 2014-01-09 2016-09-05 사노피 인슐린 유사체 및/또는 인슐린 유도체의 안정화된 약제학적 제형
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
PL2990031T3 (pl) * 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
HK1244450A1 (zh) * 2014-12-18 2018-08-10 温德加普医疗股份有限公司 用於溶解或增溶治疗剂的方法和组合物
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US11517525B2 (en) * 2015-09-18 2022-12-06 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
JP2019524896A (ja) 2016-08-25 2019-09-05 ハーロウ・ヘルス・インコーポレイテッドＨａｒｒｏｗ Ｈｅａｌｔｈ， Ｉｎｃ． 眼内投与のためのエピネフリンベースの眼科組成物及びその製造方法
RU2635759C1 (ru) * 2016-09-13 2017-11-15 Интеллег Сосьете Анониме Фармацевтическая композиция для парентерального введения и способ ее получения
US10835503B2 (en) * 2017-01-13 2020-11-17 Teva Pharmaceuticals Usa, Inc. Pre-filled syringe
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2018140894A1 (en) 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor
EP3612173B1 (en) * 2017-04-17 2023-10-11 Hikma Pharmaceuticals USA Inc. Epinephrine spray formulations
EP3687475A4 (en) * 2017-09-26 2021-07-28 YS Pharmtech STABILIZATION OF EPINEPHRIN FORMULATIONS
RU2020114880A (ru) 2017-10-10 2021-11-12 Мерк Патент Гмбх Стабилизированные инъекционные фармацевтические композиции l- эпинефрина
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
US10952962B1 (en) 2018-04-11 2021-03-23 QuVa Pharma, Inc. Ready to use liquid formulation
WO2019200076A1 (en) 2018-04-11 2019-10-17 QuVa Pharma, Inc. Ready to use liquid reck formulation
US10478406B2 (en) 2019-03-18 2019-11-19 HARC Therapeutics AG High-pH solid-state epinephrine formulation
CN116474219A (zh) * 2019-06-28 2023-07-25 四川普锐特药业有限公司 保持给药均一度的药物流体分配器及右美托咪定鼻喷器
AU2020325831B2 (en) 2019-08-08 2025-09-25 Sun Pharmaceutical Industries Limited Infusion dosage form of norepinephrine
USD1004518S1 (en) 2019-09-09 2023-11-14 Brunswick Corporation Railing for a marine vessel
US12097170B2 (en) 2020-03-06 2024-09-24 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
USD984953S1 (en) 2021-05-03 2023-05-02 Brunswick Corporation Safely railing having buoy holder
AU2021203856B2 (en) * 2021-06-10 2023-03-09 Animal Ethics Pty Ltd Topical anaesthetic composition having improved vasoconstrictor stability
AU2023332633A1 (en) * 2022-08-27 2025-04-03 Biophore India Pharmaceuticals Pvt. Ltd Trientine liquid dosage forms

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB425678A (en) 1933-06-15 1935-03-15 Novocol Chemical Mfg Co Inc Improvements relating to anesthetics for hypodermic injection
US2047144A (en) * 1934-03-26 1936-07-07 Lilly Co Eli Stabilized epinephrine-type compound, and process of stabilizing it
US2382546A (en) * 1941-11-03 1945-08-14 Curtis David Anesthetic solutions
BE617022A (cg-RX-API-DMAC7.html) 1961-04-28
US3419035A (en) * 1965-05-25 1968-12-31 Badger Meter Mfg Co Air elimination device for liquid transport system
CA981182A (en) 1972-01-07 1976-01-06 Walter A. Borisenok Stabilization of 1-epinephrine in local anesthetic solutions with a combination of three antioxidants
US3966905A (en) 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
DD150694A1 (de) 1980-04-16 1981-09-16 Gisela Raether Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
US4734438A (en) 1983-04-26 1988-03-29 Macri Frank J Norepinephrine potentiated compositions and method of use
AU5680994A (en) 1992-12-10 1994-07-04 Abbott Laboratories Stabilized catecholamine solutions
JP3535537B2 (ja) * 1993-04-15 2004-06-07 日本製薬株式会社 静脈注射剤
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
DK0941085T3 (da) 1996-11-14 2003-08-11 Alza Corp Anordning til elektrisk hjulpet uddeling af stof, såsom lidocain og ephinephrin
ES2217563T3 (es) * 1997-07-11 2004-11-01 Toray Industries, Inc. Compuestos medicinales estables que contienen derivados de 4,5-epoximorfinado.
JP4393641B2 (ja) 1998-11-26 2010-01-06 久光製薬株式会社 イオントフォレーシス用粘着ゲル組成物及びその装置
CA2424021A1 (en) 2000-09-29 2002-04-04 Board Of Trustees Operating Michigan State University Catecholamine compositions and uses thereof
WO2005033143A1 (ja) * 2003-10-01 2005-04-14 Kyowa Hakko Kogyo Co., Ltd. 抗体の安定化方法及び安定化された溶液状抗体製剤
UA71839C2 (uk) 2003-12-30 2007-06-25 Товариство З Обмеженою Відповідальністю "Фарм-Стом" Фармацевтична композиція на основі артикаїну та епінефрину
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US20060129122A1 (en) * 2004-12-06 2006-06-15 Wyrick Ronald E Method and apparatus for delivering epinephrine
WO2007123800A2 (en) 2006-04-03 2007-11-01 Nutramax Laboratories, Inc. Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound

Also Published As

Publication number Publication date
KR20120044309A (ko) 2012-05-07
JP6087145B2 (ja) 2017-03-01
WO2010139751A2 (en) 2010-12-09
CN102802668A (zh) 2012-11-28
EP2437781A2 (en) 2012-04-11
WO2010139751A3 (en) 2011-04-07
ES2432164T3 (es) 2013-12-02
EP2437782A2 (en) 2012-04-11
RU2527680C2 (ru) 2014-09-10
ES2432241T3 (es) 2013-12-02
DK2437782T3 (da) 2013-10-28
MX2011012735A (es) 2012-02-28
WO2010139752A3 (en) 2011-04-07
PT2437781E (pt) 2013-10-30
US20120129944A1 (en) 2012-05-24
SI2437781T1 (sl) 2013-12-31
AU2010255748A1 (en) 2011-12-08
WO2010139752A2 (en) 2010-12-09
MX2011012732A (es) 2012-02-28
AU2010255747B2 (en) 2014-03-13
CN106109397A (zh) 2016-11-16
RU2011153410A (ru) 2013-07-20
CA2764051A1 (en) 2010-12-09
CN102497882A (zh) 2012-06-13
AU2010255748B2 (en) 2014-03-13
PT2437782E (pt) 2013-10-30
EP2437782B1 (en) 2013-07-24
BRPI1013019A2 (pt) 2016-03-29
CA2764050A1 (en) 2010-12-09
US9155694B2 (en) 2015-10-13
BRPI1011074A2 (pt) 2016-04-12
CA2764050C (en) 2017-02-28
RU2011153403A (ru) 2013-07-20
AU2010255747A1 (en) 2012-02-02
KR20120028344A (ko) 2012-03-22
RU2527337C9 (ru) 2014-12-27
DK2437781T3 (da) 2013-10-21
JP2012528830A (ja) 2012-11-15
RU2527337C2 (ru) 2014-08-27
EP2437781B1 (en) 2013-07-24
JP2012528831A (ja) 2012-11-15

Similar Documents

Publication Publication Date Title
SI2437781T1 (sl) Stabiliziran sestavek, ki obsega vsaj eno adrenergično spojino
GB0812028D0 (en) Fungicidal compositions
EP2423182A4 (en) DIACYLETHYLENEDIAMINE COMPOUND
GB0903759D0 (en) Compound
EP2421369A4 (en) FUNGICIDE COMPOSITION
GB0800760D0 (en) Fungicidal compositions
GB0804989D0 (en) Compound
GB0822837D0 (en) Fungicidal compositions
GB0914767D0 (en) Compound
GB0803494D0 (en) Compound
GB0916938D0 (en) Cement based compound
GB0909213D0 (en) Compound
ZA201104932B (en) Phenylimidazole compounds
IL207035A0 (en) Benzylpiperizine compound
ZA201108658B (en) Fungicidal composition
EP2487178A4 (en) PYRAZOLOTHIAZOLVERBINDUNG
GB0914883D0 (en) Compound
GB0903955D0 (en) Fungicidal compositions
GB0823316D0 (en) Compound
GB0802193D0 (en) Compound
GB0820249D0 (en) Compound
GB0820919D0 (en) Compound
GB0820918D0 (en) Compound
GB0820916D0 (en) Compound
GB0820915D0 (en) Compound